## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.2% in mid entry zone (4.0-10.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (3.5%) confirms momentum alignment. Strong momentum (+3.9% 5-day acceleration). Outperforming sector by 4.4%. Caution: overbought RSI (75).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($499.62)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Why Lockheed Martin Stock Popped Today**
- Source: Finviz | 20260106T172315 | Bullish | Relevance: 100%
- Lockheed Martin's stock rose 3.6% after announcing a "landmark" contract with the U.S. Department of Defense to triple production of PAC-3 Missile Segment Enhancement interceptor missiles. This increase in production, from 600 to 2,000 missiles annually for seven years, is expected to drive significant revenue growth and improve profit margins for the company. The increased demand and operational efficiencies are seen as strong positive indicators for Lockheed Martin's financial performance.

**2. Lockheed Martin scales up PAC-3 MSE interceptor production**
- Source: Defence Blog | 20260106T143114 | Bullish | Relevance: 100%
- Lockheed Martin has reached a framework agreement with the U.S. government to significantly increase its annual production of PAC-3 MSE interceptors, from approximately 600 to 2,000 missiles over the next seven years. This ramp-up will be supported by expanded tooling, test equipment, and its extensive supplier network. The move aims to meet rising global demand for air and missile defense interceptors, driven by ongoing conflicts and the need to replenish stocks and fulfill new orders from allies.

**3. Lockheed Martin Stock Hits November 2024 Highs On Production Agreement With Department Of War**
- Source: Stocktwits | 20260106T111900 | Bullish | Relevance: 100%
- Lockheed Martin (LMT) stock reached November 2024 highs after signing a major long-term agreement with the U.S. Department of War. This deal aims to increase the annual production of PAC-3 Missile Segment Enhancement interceptors from 600 to 2,000 units, tripling output under a new seven-year framework. The agreement, part of the Department of War’s Acquisition Transformation Strategy, is expected to create thousands of new U.S. jobs and enhance the defense industrial base.

**4. Lockheed Martin Announces Fourth-Quarter and Full-Year 2025 Earnings Results Webcast**
- Source: Investing News Network | 20260106T000838 | Neutral | Relevance: 100%
- Lockheed Martin will webcast its fourth-quarter and full-year 2025 earnings results conference call on Thursday, January 29, 2026, at 8:30 a.m. ET. Company executives will discuss results and provide updates. The live webcast, presentation materials, and an on-demand replay will be available on the Lockheed Martin investor relations website.

**5. Lockheed Martin to Continue Maintenance for UAE’s THAAD Missile Defense System**
- Source: The Defense Post | 20260105T130825 | Bullish | Relevance: 100%
- Lockheed Martin secured a $142.6-million contract to prolong sustainment services for two Terminal High Altitude Area Defense (THAAD) batteries in the UAE, increasing the total project value to $876.7 million. This agreement covers logistics, training, missile and ground works, hardware and software development, engineering, and surveillance, running until August 2028. The THAAD system, a mobile air defense weapon designed to intercept ballistic missiles, has been in service with the UAE for over a decade.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $515 | $465 | +11% |
| 2025-12-16 | Morgan Stanley | $543 | $630 | -14% |
| 2025-12-12 | Citigroup | $505 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | down | Neutral |
| 2025-12-16 | Morgan Stanley | down | Equal-Weight |
| 2025-12-12 | Citigroup | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +3.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.60 elevated, pricing in significant growth expectations. Forward P/E 17.8x attractive for 33% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $121.9B |
| Beta | 0.24 |
| 52W Range | $410.11 - $537.79 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.60 |
| Forward P/E | 17.8 |
| Current P/E | 23.7 |
| YoY Growth | 33.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.3% to 7.2% (+3.9% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 89th percentile. MRS_5 at 3.5% confirms short-term momentum alignment. AM_20 at 8.1% shows strong absolute momentum above own 20MA. Outperforming sector by 4.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.16), confirming momentum. RSI overbought at 75, risk of mean reversion. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.20% (CS: 90) | Strong |
| RSI_14 | 75.1 | Overbought |
| MACD Histogram | 4.16 | Bullish |
| vs SMA20 | 1.081x | Above |
| vs SMA50 | 1.104x | Above |
| vs SMA200 | 1.119x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $522.04
- **Stop Loss:** $499.62 (4.3% risk)
- **Target:** $555.67 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 58
- **Position Value:** $30,278.32
- **Portfolio %:** 30.28%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*